-+ 0.00%
-+ 0.00%
-+ 0.00%

STOKE THERAPEUTICS - PHASE 3 DATA READOUT ANTICIPATED IN Q3 2027, TO COMPLETE NDA SUBMISSION IN H2 2027

Reuters·06/30/2026 12:00:04

Please log in to view news